Julie Hambleton

Julie Hambleton is a board member at Onc.AI. Julie has held this position for 3 years. Prior to that, they were a member of the board of directors at Gennao Bio and Erasca, Inc. Julie also served as the chief medical officer and head of development at IDEAYA Biosciences and as a strategic consultant. Hambleton has also been vice president of clinical development at Clovis Oncology and global cluster head and global group medical director at Genentech. Julie began their career as a physician and medical internist at UCSF Medical Center, where they also served as director of hemostasis and thrombosis service.

Julie Hambleton attended Case Western Reserve University from 1982 to 1986, where they studied medicine. Julie then attended Duke University.